Publikationen in Zusammenarbeit mit Forschern von University of Western Ontario (16)

2021

  1. Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study

    Journal of Psychosomatic Research, Vol. 140

  2. The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial

    Trials, Vol. 22, Núm. 1

2019

  1. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  2. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

2018

  1. Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol

    Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 91-97

  2. The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts

    Rheumatology (United Kingdom), Vol. 57, Núm. 9, pp. 1623-1631

  3. There is a need for new systemic sclerosis subset criteria. A content analytic approach

    Scandinavian Journal of Rheumatology, Vol. 47, Núm. 1, pp. 62-70

  4. Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study

    Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 98-105

2017

  1. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 270-276

2016

  1. Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

    Clinical and Experimental Rheumatology, Vol. 34, pp. 92-99

2014

  1. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

    American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61

  2. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria

    Journal of Clinical Epidemiology, Vol. 67, Núm. 6, pp. 706-714

2013

  1. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755

2012

  1. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation

    Arthritis and Rheumatism, Vol. 64, Núm. 5, pp. 1653-1664

  2. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

    Arthritis Care and Research, Vol. 64, Núm. 3, pp. 351-357

  3. Validation of potential classification criteria for systemic sclerosis

    Arthritis Care and Research, Vol. 64, Núm. 3, pp. 358-367